Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.485 AUD | +1.04% | +8.99% | -14.91% |
May. 15 | Imricor Medical Systems, Inc. to Commence 2 Clinical Trials, VISABL-AFL and VISABL-VT | CI |
May. 15 | Transcript : Imricor Medical Systems, Inc. - Shareholder/Analyst Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.91% | 64.71M | |
+6.02% | 215B | |
+9.25% | 187B | |
+19.58% | 143B | |
+29.74% | 110B | |
+1.22% | 64.68B | |
+15.27% | 52.96B | |
+2.69% | 49.84B | |
-5.47% | 38.32B | |
+1.58% | 35.86B |
- Stock Market
- Equities
- IMR Stock
- News Imricor Medical Systems, Inc.
- Imricor Medical Systems' VISABL-AFL Trial Receives Final Clearance from Swissmedic